Mikio Ueda

1.5k total citations
71 papers, 1.1k citations indexed

About

Mikio Ueda is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Mikio Ueda has authored 71 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 22 papers in Immunology and 21 papers in Oncology. Recurrent topics in Mikio Ueda's work include Hematopoietic Stem Cell Transplantation (23 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (11 papers). Mikio Ueda is often cited by papers focused on Hematopoietic Stem Cell Transplantation (23 papers), Immune Cell Function and Interaction (12 papers) and T-cell and B-cell Immunology (11 papers). Mikio Ueda collaborates with scholars based in Japan, United States and United Kingdom. Mikio Ueda's co-authors include Shinji Nakao, Shintaro Shiobara, Toshihiko Kaneshige, Akiyoshi Takami, Masaki Yamaguchi, Yuji Miura, Akihiko Yano, F Aosai, Tamotsu Matsuda and Tatsuya Chuhjo and has published in prestigious journals such as Blood, The Journal of Immunology and Clinical Infectious Diseases.

In The Last Decade

Mikio Ueda

67 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mikio Ueda Japan	18	462	422	214	197	195	71	1.1k
Pascale E. P. Dekkers Netherlands	16	358 0.8×	501 1.2×	169 0.8×	117 0.6×	388 2.0×	34	1.2k
Christoph Groth Germany	14	295 0.6×	601 1.4×	154 0.7×	92 0.5×	327 1.7×	38	1.3k
D. M. Peterson United States	13	385 0.8×	438 1.0×	49 0.2×	136 0.7×	263 1.3×	22	1.1k
L. Uharek Germany	22	796 1.7×	795 1.9×	438 2.0×	175 0.9×	302 1.5×	57	1.6k
WH Burns United States	11	425 0.9×	116 0.3×	191 0.9×	64 0.3×	279 1.4×	23	765
Motohiro Hamaguchi Japan	21	951 2.1×	191 0.5×	214 1.0×	294 1.5×	272 1.4×	69	1.7k
Nelson F. Mendes Brazil	14	149 0.3×	728 1.7×	122 0.6×	124 0.6×	274 1.4×	42	1.4k
Marc E. Uknis United States	18	87 0.2×	204 0.5×	186 0.9×	172 0.9×	595 3.1×	41	1.2k
Sanit Makonkawkeyoon Thailand	9	251 0.5×	129 0.3×	99 0.5×	324 1.6×	250 1.3×	20	862
Jaime Pérez de Oteyza Spain	17	423 0.9×	146 0.3×	228 1.1×	119 0.6×	127 0.7×	56	885

Countries citing papers authored by Mikio Ueda

Since Specialization

Citations

This map shows the geographic impact of Mikio Ueda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikio Ueda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikio Ueda more than expected).

Fields of papers citing papers by Mikio Ueda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikio Ueda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikio Ueda. The network helps show where Mikio Ueda may publish in the future.

Co-authorship network of co-authors of Mikio Ueda

This figure shows the co-authorship network connecting the top 25 collaborators of Mikio Ueda. A scholar is included among the top collaborators of Mikio Ueda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikio Ueda. Mikio Ueda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamashita, Takeshi, et al.. (2022). Measurable Residual Disease Assessment Using Next-Generation Flow in Patients With Relapsed and Refractory Multiple Myeloma Treated With a Combination of Carfilzomib, Lenalidomide, and Dexamethasone. Anticancer Research. 43(1). 157–165.

Takamatsu, Hiroyuki, et al.. (2019). Comparison of minimal residual disease detection in multiple myeloma by SRL 8-color single-tube and EuroFlow 8-color 2-tube multiparameter flow cytometry. International Journal of Hematology. 109(4). 377–381. 18 indexed citations

Hirsch, Fred R., Ramaswamy Govindan, Zanete Zvirbule, et al.. (2014). Efficacy and Safety Results From a Phase 2, Placebo-Controlled Study of Onartuzumab Plus First-Line Platinum-Doublet Chemotherapy in Advanced Squamous-Cell Non-Small Cell Lung Cancer (sq NSCLC). International Journal of Radiation Oncology*Biology*Physics. 90(5). S37–S37. 2 indexed citations

Sato, H, et al.. (2013). DECREASED I ANTIGEN EXPRESSION IN HEMATOLOGICAL MALIGNANCIES WITH REDUCED RED CELL A AND B ANTIGENS: POSSIBILITY OF BLOOD GROUP DIFFERENTIATION WITH FLOW CYTOMETRY. Japanese Journal of Transfusion and Cell Therapy. 59(3). 457–461.

Yamaguchi, Masaki, Toshiro Kurokawa, Ken Ishiyama, et al.. (2011). Efficacy and safety of micafungin as an empirical therapy for invasive fungal infections in patients with hematologic disorders: a multicenter, prospective study. Annals of Hematology. 90(10). 1209–1217. 24 indexed citations

Iwasaki, Yoshinobu, Nobuyo Tamiya, Shigekuni Hosogi, et al.. (2009). Phase II Trial of Weekly Gemcitabine and Split-dose Cisplatin for Advanced Non-small-cell Lung Cancer. Japanese Journal of Clinical Oncology. 39(12). 779–783. 5 indexed citations

Gatanaga, Hiroyuki, Tsunefusa Hayashida, K. Tsuchiya, et al.. (2007). Successful Efavirenz Dose Reduction in HIV Type 1-Infected Individuals with Cytochrome P450 2B6 *6 and *26. Clinical Infectious Diseases. 45(9). 1230–1237. 169 indexed citations

Iwasaki, Yoshinobu, Mikio Ueda, Hiroshi Hara, et al.. (2006). Phase I/II trial of biweekly docetaxel and cisplatin with concurrent thoracic radiation for stage III non-small-cell lung cancer. Cancer Chemotherapy and Pharmacology. 58(6). 735–741. 9 indexed citations

Okumura, Hirokazu, Masaki Yamaguchi, Naomi Sugimori, et al.. (2006). Graft rejection and hyperacute graft‐versus‐host disease in stem cell transplantation from non‐inherited maternal antigen complementary HLA‐mismatched siblings. European Journal Of Haematology. 78(2). 157–160. 9 indexed citations

10.

Yamaguchi, Masaki, et al.. (2006). Successful Treatment of Refractory Peripheral T-Cell Lymphoma with a Combination of Fludarabine and Cyclophosphamide. International Journal of Hematology. 83(5). 450–453. 4 indexed citations

11.

Miura, Yuji, Mikio Ueda, Akiyoshi Takami, et al.. (2003). Enhancement of cyclosporin A-induced autologous graft-versus-host disease after peripheral blood stem cell transplantation by utilizing selected CD34+ cells. Bone Marrow Transplantation. 32(8). 785–790. 4 indexed citations

12.

Yamaguchi, Masaki, et al.. (2002). Treatment of pure red cell aplasia after major ABO-incompatible peripheral blood stem cell transplantation by induction of chronic graft-versus-host disease. Bone Marrow Transplantation. 30(8). 539–541. 17 indexed citations

13.

Shiobara, Shintaro, Shinji Nakao, Mikio Ueda, et al.. (2001). Donor Leukocyte Infusion for Japanese Patients with Relapsed Leukemia After Allogeneic Bone Marrow Transplantation: Indications and Dose Escalation. Therapeutic Apheresis. 5(1). 40–45. 18 indexed citations

14.

Takami, Akiyoshi, et al.. (2000). Successful treatment of B-cell lymphoma associated with hemophagocytic syndrome using autologous peripheral blood CD34 positive cell transplantation followed by induction of autologous graft-versus-host disease. Annals of Hematology. 79(7). 389–391. 4 indexed citations

15.

Shiobara, Shintaro, Shinji Nakao, Mikio Ueda, et al.. (2000). Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome. Bone Marrow Transplantation. 26(7). 769–774. 60 indexed citations

16.

Nakao, Shinji, Akiyoshi Takami, Naomi Sugimori, et al.. (1996). Response to immunosuppressive therapy and an HLA‐DRB1 allele in patients with aplastic anaemia: HLA‐DRB1*1501 does not predict response to antithymocyte globulin. British Journal of Haematology. 92(1). 155–158. 17 indexed citations

17.

Harada, M, Mikio Ueda, Kenta Kondo, et al.. (1986). Nonspecific suppressor T cells cause decreased mixed lymphocyte culture reactivity in bone marrow transplant patients.. The Journal of Immunology. 137(2). 428–432. 14 indexed citations

18.

Nakao, Shinji, Mine Harada, Mikio Ueda, et al.. (1986). Enhancement of in vitro erythropoiesis by peripheral blood mononuclear cells from allogeneic marrow recipients in the early post‐transplant period. Scandinavian Journal of Haematology. 36(2). 180–185. 5 indexed citations

19.

Saito, Haruo, et al.. (1977). The Intra-Aural Reflex Elicited after Stapedectomy (False Positive Response). AUDIOLOGY JAPAN. 20(2). 110–114. 2 indexed citations

20.

Ueda, Mikio, et al.. (1958). A Case of Aluminium Dust Lung. A Necropsy Report.. Kobe University Repository Kernel (Kobe University). 4(2). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact